Previous Section Back to Table of Contents Lords Hansard Home Page

Question

Asked by Lord Bates

The Chancellor of the Duchy of Lancaster (Baroness Royall of Blaisdon): The current purchase price for a 500-sheet ream of white A4 80 gsm photocopier paper paid by (a) the Equality and Human Rights Commission was £1.96 and (b) the Government Equalities Office was £2.17.

Greece

Question

Asked by Lord Stoddart of Swindon

The Financial Services Secretary to the Treasury (Lord Myners): Membership of the European Union does not impose any obligation on the UK to contribute to any financial rescue, or accept the debt obligations, of any EU member state. There has been no request for UK support. Any such requests are considered on their individual merits.

Health: Expenditure

Questions

Asked by Lord Warner

Baroness Thornton: Pharmaceuticals (drugs) expenditure includes National Health Service expenditure in primary care and the Hospital and Community Health Service (HCHS). The primary care expenditure reflects amounts paid to pharmacy and appliance contractors and amounts authorised for dispensing doctors and personal administration in England. This includes expenditure on the seasonal influenza and adult pneumococcal vaccines, which are procured and administered by general practitioners and other contractors.

Table 1 provides details of NHS expenditure on drugs in cash and real terms (2008-09 base year).

Table 1: NHS expenditure on drugs
£ millionNHS drugs expenditure
YearCashReal Terms

1996-97

4,735

6,323

2003-04

9,271

10,541

2005-06

9,979

10,837

2008-09

11,378

11,378

2009-10 (April to September primary care)

3,796

3,722

Sources:

Prescription Pricing Division of the NHS Business Services Authority, England, Department of Health Finance Division, Foundation Trust year-end accounts.

Notes:

1. Government accounting policy changed in 2000-01; as a result, figures prior to 2000-01 are not strictly comparable to figures thereafter. Expenditure prior to 2000-01 represents the amounts paid between April to March for medicines and appliances and relate to prescriptions dispensed between March and February. This is due to the delay in prescription processing and payment calculations. From 2000-01, figures represent the actual cost of the prescriptions for medicines and appliances dispensed in the period April to March.

2. Year-to-date primary care figures have been provided for 2009-10. We do not have HCHS figures, which are sourced from

27 Jan 2010 : Column WA346

accounts information available at year-end only. Primary care drugs expenditure is approximately 70 per cent of total NHS drugs expenditure.

3. Real-term calculation uses GDP deflator series at January 2010, 2008-09 = 100.

Additionally, the department provides centrally purchased vaccines for the NHS routine childhood immunisation programme and catch up programmes, vaccines against anthrax, rabies, smallpox, and the swine influenza vaccination programme 2009-10. The department is not able to divulge expenditure on swine influenza vaccine as it would violate confidentiality clauses in the contracts with the manufacturers. The available information about the department's expenditure on vaccines for England (not including swine influenza vaccine) is given in Table 2 in cash and real terms (2008-09 base year).

Table 2: Department of Health expenditure on vaccines
£ millionVaccines
YearCashReal Terms

1996-97

-

-

2003-04

88

101

2005-06

107

116

2008-09

229

229

2009-10 (April to December)

160

157

Notes:

1. Where relevant, figures for England have been calculated as 84 per cent. of expenditure on vaccines for the United Kingdom. Childhood vaccines and smallpox vaccine are purchased for the UK. Anthrax and rabies vaccines are purchased for England and Wales.

2. Year-to-date figures to December 2009 have been supplied for 2009-10.

3. Real-term calculation uses GDP deflator series at January 2010, 2008-09 = 100.

The vaccines provided for NHS programmes have changed over the period of time shown in the table. For example, the higher level of expenditure in 2008-09 partly reflects the addition of human papilloma virus vaccination against cervical cancer.

Information about vaccine expenditure in 1996-97 is not available. It has not been possible to confirm whether or not records of vaccine expenditure for 1996-97 have been retained centrally by the department and there is no obligation for such records of this age to be retained.

Asked by Lord Warner

Baroness Thornton: The department does not collect detailed expenditure information in these areas since, subject to delivering national targets, there is local discretion on how the funding is spent. However, for public health and prevention, a report by Health England shows (mostly using end of year information) expenditure in England on public health and prevention

27 Jan 2010 : Column WA347

for 2006-07. See Table 3 in the Report: Health England Report No 4. Public Health and Prevention Expenditure in England 2009, which is available from: http://healthengland.org/health_england_publications.htm.



27 Jan 2010 : Column WA348

Table 3 in that report is replicated here as follows, entitled Table 1, and provides a breakdown of spending based as closely as possible on Organisation for Economic Co-operation and Development (OECD) definitions

Table 1: Detailed Prevention Expenditure in England 2006-07
Primary preventionSecondary preventionTotal £m
ScreeningOtherMedication

Total prevention and public health services

1,771

1,482

482

1,337

5,072

Maternal and child health; family planning and counselling

840

21

0

0

861

Maternity services

618

618

Family Planning Clinics

101

101

Contraceptives

66

66

Health Visiting Group Services

53

53

Neonatal audiological screening

14

14

Quality and Outcomes Framework (1)

2

6

9

School health services

44

0

115

0

159

School-based Children's Individual Health Services

115

115

School-based Children's Group Health Services

27

27

Healthy Schools Programme (2)

17

17

Prevention of communicable diseases

284

0

0

0

284

Immunisation (2)

238

238

Other infectious diseases (2)

24

24

Quality and Outcomes Framework

19

19

Reducing MRSA incidence (2)

3

3

Prevention of non-communicable diseases

206

1,461

348

1,337

3,352

Pharmaceuticals

1,337

1,337

Dental check-ups

937

937

Quality and Outcomes Framework

28

41

348

417

Screening programmes

275

275

Sight tests

208

208

Obesity/diet/lifestyle

116

116

NHS Stop Smoking Services

56

56

NICE Public Health Guidelines

4

4

CJD surveillance (2)

2

2

Occupational health care

4

0

0

0

4

Occupational Health for Dentists

4

4

Quality and Outcomes Framework

1

1

All other miscellaneous public health services (1)

394

0

19

0

412

Health Protection Agency

248

248

NHS Blood and Transplant (2)

53

53

Publicity for prevention activities

34

34

Charitable expenditure on prevention

33

33

National Biological Standards Board

25

25

Public Health in Prisons (2)

19

19

Source:

Health Inequalities and Partnership, DH (Health England Report No 4. Public Health and Prevention Expenditure in England 2009)

Notes:

1. Figures may not sum due to rounding

2. Refers to expenditure from the central budget, data available only for 2006-07


Next Section Back to Table of Contents Lords Hansard Home Page